Medical/Pharmaceuticals

CANbridge to Participate in Two Investor Conferences in September

BEIJING and BURLINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today a...

2023-09-06 16:06 1443

Alma welcomes the iconic Hollywood superstar, Kate Hudson as its new Global Brand Ambassador

* The long-term partnership aims to emphasize the empowerment of natural beauty, with Alma committed to delivering safe, effective, and evidence-based solutions. * The actress and entrepreneur will be featured in a brand-new campaign themed "Beyond the Trend," highlighting reliable aesthetic ...

2023-09-06 15:24 1932

HEALTH INNOVATIONS ACQUIRES ASKDR, A SINGAPORE-BASED DIGITAL HEALTH START-UP

SINGAPORE, Sept. 6, 2023 /PRNewswire/ -- Health Innovations, a consortium of practising medical doctors from GP+ cooperative, is pleased to announce its acquisition of AskDr , a leading digital ...

2023-09-06 15:15 1942

Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM

MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held inVienna from 9...

2023-09-06 14:18 1413

Zimmer Biomet India Launches Zimmer Biomet on Wheels Campaign

NEW DELHI, Sept. 6, 2023 /PRNewswire/ -- Zimmer Biomet India today announced the launch of the Zimmer Biomet on Wheels campaign, a mobile vehicle housing the company's innovative products and solutions, including Knee, Hips, Shoulder, and Sports Medicine product portfolios that leverage data, ana...

2023-09-06 11:30 1840

MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

GENEVA, Sept. 6, 2023 /PRNewswire/ -- The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where ...

2023-09-06 08:00 1516

MALAYSIA HEALTHCARE TRAVEL COUNCIL SELECTS MAYO CLINIC TO PROVIDE STRATEGIC COUNSEL TO FURTHER ADVANCE MEDICAL EXCELLENCE IN MALAYSIA

PUTRAJAYA, Malaysia, Sept. 5, 2023 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), an agency established under the purview of Ministry of Health Malaysia, has officially announced the successful establishment of a Memorandum of Understanding (MoU) with US-basedMayo Clinic

2023-09-05 22:37 1761

SIBIONICS Launches the Breakthrough SIBIO KS1 CKM for Ketone Level Monitoring

SHENZHEN, China, Sept. 5, 2023 /PRNewswire/ -- SIBIONICS, a leader in bio-wearable consumer electronics, is pleased to announce the launch of SIBIO KS1 Continuous Ketone Monitoring (CKM) System, the company's newest biometric wearable device designed to measure ketone levels. Boasting CE certific...

2023-09-05 21:56 2048

Exosomes functionally deliver siRNAs in vivo to repress tumor growth

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou,China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delivery in vitro and in vivo" (doi:https://doi.org/10.1101/2023.0...

2023-09-05 21:20 1539

YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference

GAITHERSBURG, Md., Sept. 5, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious di...

2023-09-05 20:30 1436

Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile

Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages.  Compared with other commercially available hyaluronidase products, Tergase® showed no incidence of anti-drug antibodies (ADA).  The occurrence of ADA is known ...

2023-09-05 20:00 983

David Topper Joined Inmagene as CFO

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...

2023-09-05 20:00 1339

I-Mab Announces Upcoming Participation at September Conferences

ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies an...

2023-09-05 20:00 1202

Baird Medical's Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China

GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., h...

2023-09-05 17:00 1125

CIGNA HEALTHCARE LAUNCHES NEW GLOBAL HEALTH BENEFITS PLAN FOR ADULTS AGED 60+

* Bespoke solution designed to meet growing consumer demand for international health coverage * Includes full cancer coverage and benefits to support health and well-being across all areas of life * Includes optional outpatient cover for certain chronic conditions, including type 2 diabetes...

2023-09-05 15:00 1570

European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies

HEIDELBERG, Germany, Sept. 5, 2023 /PRNewswire/ -- A ground-breaking research collaboration between European Wellness Biomedical Group (EWBG), through its subsidiaries European Wellness Academy (EWA) and Baden R&D Laboratories (Baden), and Heidelberg's Institute of Anatomy and Cell Biology has yi...

2023-09-05 14:06 1724

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1079

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001

*  Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform *  ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data *  ACM is in partnering d...

2023-09-05 14:00 1417

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1353

Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare

* The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and development is also critical for patient-centred care.1 * The report surveyed 10 countries, al...

2023-09-05 13:00 3732
1 ... 79808182838485 ... 577